Literature DB >> 11098311

Responsible use of blood products in response to supply and demand.

K Colgan1, M L Moody, K Witte.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11098311     DOI： 10.1093/ajhp/57.22.2094

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  2 in total

1.  Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation.

Authors:  M M Stollenwerk; I Pashkunova-Martic; C Kremser; H Talasz; G C Thurner; A A Abdelmoez; E A Wallnöfer; A Helbok; E Neuhauser; N Klammsteiner; L Klimaschewski; E von Guggenberg; E Fröhlich; B Keppler; W Jaschke; P Debbage
Journal:  Histochem Cell Biol       Date:  2010-02-20       Impact factor: 4.304

2.  Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis.

Authors: 
Journal:  CADTH Technol Overv       Date:  2010-03-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.